Cheng He

Title: Cheng He and Avian Immunopotentiation

Introduction

Cheng He is an inventor based in Beijing, China, whose patent work concerns the use of β-glucan extracts to support immune responses in avian animals. His listed patent portfolio includes 1 patent, and his company affiliation is Lesaffre et Compagnie.

Latest Patents

His patent, “Use of beta-glucan extract in the immunopotentiation of an avian animal,” describes a kit combining an immunopotentiator with a virus vaccine. The immunopotentiator contains a β-glucan extract derived from cell walls.

The invention also describes using the extract to prepare an immunopotentiator or a kit for avian immunopotentiation. According to the patent description, the approach may enhance lymphocyte proliferation and T-cell responses in vaccinated animals, reduce viral load and disease outcomes, promote earlier antibody production, increase antibody levels, and help restrict viral spread.

Career Highlights

A key focus of He’s disclosed invention is combining a cell-wall-derived β-glucan extract with vaccination to strengthen immune responses in avian animals. The patent presents potential applications in supporting vaccine performance and limiting the effects and transmission of viral infections.

Collaborations

The supplied information identifies Tianyuan Zhang and Tadele Kiros Gebreyohannes as He’s coworkers. It does not specify their roles in the patent or describe particular collaborative contributions.

Conclusion

Cheng He’s patent highlights an approach to avian immunopotentiation that pairs a β-glucan extract with a virus vaccine, with the stated aim of improving immune responses and helping control viral disease.